123 related articles for article (PubMed ID: 32972114)
21. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
22. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
24. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
Costa BM; Caeiro C; Guimarães I; Martinho O; Jaraquemada T; Augusto I; Castro L; Osório L; Linhares P; Honavar M; Resende M; Braga F; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires M; Pinheiro C; Carvalho E; Lopes JM; Costa P; Damasceno M; Reis RM
Oncol Rep; 2010 Jun; 23(6):1655-62. PubMed ID: 20428822
[TBL] [Abstract][Full Text] [Related]
26. Impact of Immunohistochemical profiling of Glioblastoma multiforme on clinical outcomes: Real-world scenario in resource limited setting.
Kumar N; Elangovan A; Madan R; Dracham C; Khosla D; Tripathi M; Gupta K; Kapoor R
Clin Neurol Neurosurg; 2021 Aug; 207():106726. PubMed ID: 34116459
[TBL] [Abstract][Full Text] [Related]
27. Impact of standard care on elderly glioblastoma patients.
Lapointe S; Florescu M; Simonyan D; Michaud K
Neurooncol Pract; 2017 Mar; 4(1):4-14. PubMed ID: 31385982
[TBL] [Abstract][Full Text] [Related]
28. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
29. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma.
Roberts PS; Nuño M; Sherman D; Asher A; Wertheimer J; Riggs RV; Patil CG
PM R; 2014 Jun; 6(6):514-21. PubMed ID: 24384359
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide for patients with wild-type isocitrate dehydrogenase (IDH) 1 glioblastoma using propensity score matching.
Tunthanathip T; Sangkhathat S
Clin Neurol Neurosurg; 2020 Apr; 191():105712. PubMed ID: 32036239
[TBL] [Abstract][Full Text] [Related]
31. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
Polley MY; Lamborn KR; Chang SM; Butowski N; Clarke JL; Prados M
Neuro Oncol; 2010 Mar; 12(3):274-82. PubMed ID: 20167815
[TBL] [Abstract][Full Text] [Related]
32. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
Saito T; Muragaki Y; Maruyama T; Komori T; Nitta M; Tsuzuki S; Fukui A; Kawamata T
Neurosurg Rev; 2020 Dec; 43(6):1583-1593. PubMed ID: 31705405
[TBL] [Abstract][Full Text] [Related]
33. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.
Darefsky AS; King JT; Dubrow R
Cancer; 2012 Apr; 118(8):2163-72. PubMed ID: 21882183
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma survival in the United States before and during the temozolomide era.
Johnson DR; O'Neill BP
J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.
Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G
Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
37. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
Topkan E; Kucuk A; Ozdemir Y; Mertsoylu H; Besen AA; Sezen D; Bolukbasi Y; Pehlivan B; Selek U
J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
[TBL] [Abstract][Full Text] [Related]
39. Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study.
Ebad Ur Rehman M; Faraz F; Cheema HA; Ashruf OS; Raheel H; Naqvi SZA; Jabeen N; Abid A; Mumtaz Malik H; Iftikhar A; Ibrahim A; Swed S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1984. PubMed ID: 38389401
[TBL] [Abstract][Full Text] [Related]
40. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.
McGirt MJ; Than KD; Weingart JD; Chaichana KL; Attenello FJ; Olivi A; Laterra J; Kleinberg LR; Grossman SA; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2009 Mar; 110(3):583-8. PubMed ID: 19046047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]